HCQ tx thresholds study by Prof Garg: 🔸HCQ >=500ng/ml: good threshold to detect adherence 🔸HCQ 750-1000ng/ml: effective thresholds to prevent flares 🔸CKD>=2: 4x ⬆️odds of HCQ>1500ng/ml (supraTx! dose adj.) Interesting data. Game changing?🧐 #ACR22 @RheumNow ABST#0344 #ACRBest https://t.co/GxlucrTeE5

Interesting data on TNFi use in ankylosing spondylitis. Early TNFi use, compared to no TNFi associated with higher CVD, stroke and MACE. @rheum_cat any thought on why? and why there were so many non-TNFi users (15k vs. 2k)? Abs#0415 @RheumNow #ACR22 https://t.co/PVkt8gPHFW

ACEi improve survival in SSc Renal Crisis ◦ Routine use of ACEi as prophylaxis is a myth ◦ ACEi prophylaxis may set up a chronic, less reversible process ◦ Best used in high BP, low creatinine - bring on the ACEi then John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/3leCEmtaj1

Add GPA to the list of causes of dacryoadenitis (inflammation of the lacrimal gland, main or accessory). Differential diagnoses of dacryoadenitis: ● Sjogren's ● Sarcoidosis ● IgG4 RD ● AL Amyloidosis ● GPA John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/dvXbkpfcAq

After an incredible 2.5 years for the COVID-19 GRA @rheum_covid, @philipcrobinson addresses the celebration of all that’s been achieved at #ACR22 - followed by @JYazdanyMD @pedrommcmachado @rheum_cat and more Congratulations to all who have been involved! @RheumNow https://t.co/jO5c6yRI6F

Learn the terms used by the ophthalmologists: ◦ KP ◦ PUK ◦ IOI ➢ PUK is a medical emergency ➣ Think RA, AAV in PUK John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/yVGRpjrijN

This quality improvement proj by Dr Gennaoui et al assessed MD compliance in HCQ eye screening 👇 After an educ intervention, 👀 specialist documentation available ☑️significantly MD doc & uptodate screening also ⬆️not sig(p>0.05) Screen pts on HCQ. #ACR22 @RheumNow ABST#0346 https://t.co/IPAxXsp3Lu

Doppelgängers are double walkers with similar features. GPA and IgG-RD are doppelgängers. 3 findings in GPA that are not found in IgG4-RD: ◦ Granulomatous inflammation ◦ Necrosis ◦ Neutrophilic infiltration John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/F67EhGBcS4

Hear what KOLs are saying about #ACR22. We are featuring Drs: Michele Petri, Peter Nash, Artie Kavanaugh, Jack Cush. Follow us on Twitter and head to https://t.co/V10S4oVFsv! https://t.co/uRZLffesrq

Treating the underlying CTD is key to managing ILD in combination with anti-fibrotic. In the SENCIS study, patients on combination of MMF at baseline +Nintedanib had reduced decline in FVC compared to Nintedanib alone https://t.co/NmVRZ44JGE Paul Noble #ACR22 @RheumNow https://t.co/mulaBK61ga